Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tetraphase Pharmaceuticals

2.20
0.0000
Volume:- -
Turnover:- -
Market Cap:15.98M
PE:-0.17
High:2.20
Open:2.20
Low:2.20
Close:2.20
Loading ...
May 07, 2020

Business Combinations

Prospectuses and communications, business combinations
Apr 30, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Apr 28, 2020

Major Issues Report

Current report, items 1.01, 2.03, and 9.01
Mar 25, 2020

Business Combinations

Prospectuses and communications, business combinations
Mar 20, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 17, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Mar 16, 2020

Business Combinations

Prospectuses and communications, business combinations
Mar 16, 2020

Business Combinations

Prospectuses and communications, business combinations
Mar 16, 2020

Major Issues Report

8-K - Current report
Mar 12, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 28, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 23, 2020

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Jan 23, 2020

Major Issues Report

Current report, items 1.01, 2.02, 3.02, 5.02, 8.01, and 9.01
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 08, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Oct 30, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01